Starting from the initial studies carried out on autoantibodies, considerable progress has been made in identifying other possible molecular mechanisms implicated in the activation of NF-κB, which could explain the chronic inflammatory situation characteristic of SS. Here, NFKB1 is linked to synovial sarcoma.